Iwasaki Yoichi, Tomiyama Hirofumi, Shiina Kazuki, Matsumoto Chisa, Nakano Hiroki, Fujii Masatsune, Yamashina Akira, Chikamori Taishiro
Department of Cardiology, Tokyo Medical University Tokyo Japan.
Circ Rep. 2019 Aug 30;1(9):372-377. doi: 10.1253/circrep.CR-19-0057.
The precise mechanisms underlying elevation of serum N-terminal pro-brain natriuretic peptide (NT-proBNP) in healthy subjects have not been fully clarified. In 2,844 Japanese healthy subjects with serum NT-proBNP <125 pg/mL, (1) brachial-ankle pulse wave velocity and (2) second peak of the peripheral systolic blood pressure minus diastolic blood pressure (pulse pressure 2 [PP2]), as markers of cardiac afterload; (3) fibrosis 4 score (FIB-4 score, a marker of liver fibrosis), as a marker of cardiac preload; and (4) ratio of the pre-ejection time to ejection time (PEP/ET), as a marker of cardiac systolic function, were measured. At the first examination, after the adjustments, log-transformed serum NT-proBNP was associated with PP2 and FIB-4 score, but not with PEP/ET. These parameters were successfully measured again after a 3-year interval in 1,978 subjects. On Pearson's correlation analysis, change in PP2 and FIB-4 score during the study period was significantly correlated with change in serum NT-proBNP (r=0.05, 0.09, respectively; P<0.01). In apparently healthy Japanese subjects, both increased cardiac preload and increased cardiac afterload, but not impaired cardiac systolic function, may be associated with elevated serum NT-proBNP.
健康受试者血清N末端脑钠肽前体(NT-proBNP)升高的精确机制尚未完全阐明。在2844名血清NT-proBNP<125 pg/mL的日本健康受试者中,测量了以下指标:(1)臂踝脉搏波速度和(2)外周收缩压减去舒张压的第二个峰值(脉压2[PP2]),作为心脏后负荷的标志物;(3)纤维化4评分(FIB-4评分,肝纤维化标志物),作为心脏前负荷的标志物;以及(4)射血前期与射血时间之比(PEP/ET),作为心脏收缩功能的标志物。在首次检查时,调整后,对数转换后的血清NT-proBNP与PP2和FIB-4评分相关,但与PEP/ET无关。1978名受试者在3年间隔后再次成功测量了这些参数。经Pearson相关性分析,研究期间PP2和FIB-4评分的变化与血清NT-proBNP的变化显著相关(r分别为0.05、0.09;P<0.01)。在表面健康的日本受试者中,心脏前负荷增加和心脏后负荷增加,而非心脏收缩功能受损,可能与血清NT-proBNP升高有关。